Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Therapy for Pulmonary Arterial Hypertension in Adults
2019
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention
2010
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
New Antithrombotic Drugs
2008
New Antithrombotic Drugs
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
A global view of pulmonary hypertension
2016 Standout
Systemic sclerosis
2017 Standout
Antiplatelet Drugs
2011
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
2013
Artificial Intelligence in Precision Cardiovascular Medicine
2017 Standout
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
2011 Standout
Ticagrelor
2011
High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy
2013
Ticagrelor
2011
Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database
2015
Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults
2014
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
2011
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
2011
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
2015
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Highly Stereoselective Biocatalytic Synthesis of Key Cyclopropane Intermediate to Ticagrelor
2016 StandoutNobel
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
2012
Transparent and flexible fingerprint sensor array with multiplexed detection of tactile pressure and skin temperature
2018 Standout
Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction
2012
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
2015
Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on‐treatment platelet reactivity
2011
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
2011
Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases
2018
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
2010
Impaired platelet P2Y12 inhibition by thienopyridines in chronic kidney disease: mechanisms, clinical relevance and pharmacological options
2013
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network
2018 Standout
Atherosclerosis
2019 Standout
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
2011
New concepts in the design of drug-eluting coronary stents
2013
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention
2013
What’s new in the treatment of portopulmonary hypertension?
2015
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Coronary Stents
2010
Antiplatelet agents for the treatment and prevention of atherothrombosis
2011
Ticagrelor: a P2Y12antagonist for use in acute coronary syndromes
2012
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
2014
Antithrombotic Therapy in Patients With Chronic Kidney Disease
2012
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
2010
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Advances of flexible pressure sensors toward artificial intelligence and health care applications
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease
2012
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Machine Learning and Deep Learning in smart manufacturing: The Smart Grid paradigm
2021 Standout
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
2014
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
2010
Flexible and Stretchable Physical Sensor Integrated Platforms for Wearable Human‐Activity Monitoringand Personal Healthcare
2016 Standout
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Part 8: Post–Cardiac Arrest Care
2015 Standout
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Metallic implant biomaterials
2014 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise
1987
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
Works of Keyur Parikh being referenced
Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension
2013
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial
2009
Wireless Acoustic Communication With a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients With Congestive Heart Failure
2007
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation
2009
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial
2012
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
2009
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
2010
Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
1985